You are here

CDUHR Weekly Update - September 26, 2016


AIDS Seminar
It’s All in the Mix: How Mixed Methods Enhance (and Complicate) HIV Prevention Research
Tuesday, October 11, 10:30-11:30am
Lisa Bowleg, PhD - George Washington University
NYU Meyers College of Nursing, 433 First Ave, Room 760
Find more information HERE.


CHEST 20th Anniversary Symposium
Past, Present and Future of HIV Research to Policy
Tuesday, September 27, 1:00-6:00pm
The symposium will focus on the research-policy-practice connections related to HIV/AIDS and LGBT health, and will be divided into three sections. PAST: Re-examining policy-influencing studies from CHEST's 20-year history.
Roosevelt House Public Policy Institute at Hunter College
47-49 East 65th Street, New York
Find more information HERE.
The event is free but registration is required and limited - register HERE.

NYU Health Sciences Library
2nd Data Visualization Clinic
Friday, September 30, 10:00-11:30am
The clinic is space for anyone with a visualization to come and present their work and receive constructive feedback from NYU Langone data visualization enthusiasts.
Find more information and register HERE.

NYU School of Medicine and NYC Health + Hospitals
Health Disparities Symposium
Tuesday, October 18, 8:15am-3:30pm
Farkas Auditorium, NYU Langone Medical Center, 550 First Avenue
Find more information and register HERE.

New York Academy of Sciences Event
Grantsmanship for Students and Postdocs: F30, F31, F32
Wednesday, November 2, 6:00-8:30pm
Seminar and follow up panel will focus on best practices for effective grant writing, specifically applied to individual pre-doctoral and post-doctoral fellowship applications in the biomedical fields.
Find more information and register HERE.


Drug Abuse Dissertation Research (R36)
The goal of this FOA is to enhance the diversity of the drug abuse research workforce by providing dissertation awards on topics related to the study of basic and clinical neuroscience, development, epidemiology, prevention, treatment, services, or women and sex/gender differences as they relate to drug abuse.

Improving the HIV Pre-Exposure Prophylaxis (PrEP) Cascade
This FOA invites applications that will strengthen the HIV oral pre-exposure prophylaxis (PrEP) care continuum by developing and testing interventions to improve PrEP care engagement and retention among individuals at substantial risk for HIV infection, as well as interventions to support PrEP medication adherence and persistence as indicated.

Model Continuums of Care Initiative (MCCI) for Women and Girls at Risk and Living With HIV/AIDS and Harmful Alcohol and Associated Comorbidities Planning Cooperative Agreement (U34)
The purpose of the Model Continuums of Care Initiative (MCCI) for Women and Girls at Risk and Living with HIV/AIDS and Harmful Alcohol and Associated Comorbidities Initiative is to promote the development and evaluation of integrated multilevel interventions to reduce alcohol consumption as a key approach to preventing new infections and enhancing treatment adherence in communities in the U.S. where racial and ethnic minority women bear a disproportionate share of the HIV/AIDS disease burden.

Collaborative Research in HIV/AIDS, Alcohol, and Related Comorbidities (Collaborative U01)
This FOA encourages new research into the identification, analysis, and treatment of HIV/AIDS and associated comorbidities impacted by alcohol use (e.g., Hep C, TB, Depression, HAND, other associated substance use, including medication polypharmacy) by fostering collaborations between NIAAA-supported investigators and those currently unaffiliated with the NIAAA HIV/AIDS research activities.

Expanding Alcohol-Focused High-Priority Translational Research for HIV/AIDS (UH2/UH3)
This FOA is a new initiative to support the development of highly innovative HIV/AIDS and alcohol-relevant high-priority research suitable for advancing the translation of basic biological and behavior science research into clinical practice through improved interventions for prevention and treatment among HIV+ individuals.

Support of Competitive Research (SCORE)
The SCORE Program is a developmental program designed to increase the research competitiveness of faculty and research capacity of institutions with an explicitly stated historical mission and/or a demonstrated historical track record of training and graduating students from backgrounds underrepresented in biomedical research.
(SC1 - Research Advancement)
(SC2 - Pilot Project)
(SC3 - Research Continuance)

Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Paediatric Research Grant Programme
The CIPHER Grant Programme is designed for mentored early-stage investigators to advance paediatric HIV research and to fill critical knowledge gaps that impede paediatric HIV diagnosis, prevention, treatment and care in resource-limited settings.

Notice of Intent to Publish a Funding Opportunity Announcement for Integrated Approaches to HIV-Related Heart, Lung, Blood, and Sleep Comorbidities (R01)
NHLBI intends to promote a new initiative by publishing an FOA to solicit applications for research on the molecular mechanisms underlying HIV-related heart, lung, blood, and sleep (HLBS) comorbidities.

Notice of Intent to Publish a Funding Opportunity Announcement for ImPlementation REsearCh to DEvelop interventions for People Living with HIV (PRECluDE) (U01)
NHLBI intends to promote a new initiative by publishing an FOA to solicit applications for research on implementation research in the delivery of proven effective interventions for comorbid heart, lung, blood, and sleep (HLBS) diseases and conditions in people living with HIV/AIDS (PLWHIV) domestically. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.


The Office of Disease Prevention (ODP) at the NIH is inviting submissions for the ODP Early-Stage Investigator Award. This inaugural award will recognize early-career prevention scientists who have already made substantial, outstanding research contributions to their respective fields and are poised to become future leaders in prevention research. Find more information HERE to nominate that hard-working, extra special early-stage investigator!

NIAID provides some advice for addressing rigor and reproducibility in your next proposal in their latest newsletter. Remember, these now need to be addressed in most types of applications submitted. Find it in the NIAID newsletter HERE.


Jõgeda EL, Huik K, Pauskar M, Kallas E, Karki T, Des Jarlais D, Uuskula A, Lutsar I, & Avi R (2016) Prevalence and genotypes of GBV-C and its associations with HIV infection among persons who inject drugs in Eastern Europe. Journal of Medical Virology, doi: 10.1002/jmv.24683. Find the abstract on the publisher's website HERE.

Koblin BA, Egan JE, Nandi V, Sang JM, Cerda M, Tieu HV, Ompad DC, Hoover DR, & Frye V (2016) Congruence of home, social and sex neighborhoods among men who have sex with men, NYCM2M study. Journal of Urban Health, doi: 10.1007/s11524-016-0074-5. Find the abstract on the publisher's website HERE.

Palamar JJ, Acosta P, Ompad DC, & Cleland CM (2016) Self-reported ecstasy/MDMA/“Molly” use in a sample of nightclub and dance festival attendees in New York City. Substance Use and Misuse, doi: 10.1080/10826084.2016.1219373. Find the abstract on the publisher's website HERE.

Park SH, Duncan DT, El Shahawy O, Shearston JA, Lee L, Tamura K, Sherman SE, & Weitzman M (2016) Analysis of state-specific prevalence, regional differences, and correlates of hookah use in U.S. adults, 2012-2013. Nicotine & Tobacco Research, doi: 10.1093/ntr/ntw229. Find the abstract on the publisher's website HERE.


Conference on Retroviruses and Opportunistic Infections (CROI)
February 13-16, 2017 – Seattle, WA
Abstracts & Young Investigator Scholarships are due by September 28

25th Harm Reduction International Conference
May 14-17, 2017 – Montréal, Canada
Abstracts are being accepted through October 21